Rates of cervical precancer dropped nearly 80% between 2008 and 2022 among screened women aged 20 to 24, according to the latest Morbidity and Mortality Weekly Report from Centers for Disease … Continued
What do you feel holds great promise in the field of ovarian cancer research and treatment? “We have made great progress in understanding the molecular biology of ovarian cancer. Continuing efforts … Continued
No, a Pap smear does not test for ovarian cancer; it screens for cervical cancer. In fact, no reliable screening or early detection tests exist for ovarian cancer. What is … Continued
A recent study from Cancer Nursing has shed more light on the profound impact gynecologic cancer has on survivors, even after treatment. In particular, the study highlighted the prevalence of … Continued
Fewer people each year are being diagnosed with ovarian cancer. Why do you feel the numbers are decreasing? OCRA’s Scientific Advisory Committee (SAC) is composed of doctors and researchers who … Continued
Share your thoughts on multi-cancer detection tests and what role they might have, or not, for ovarian cancer? OCRA’s Scientific Advisory Committee (SAC) is comprised of doctors and researchers who … Continued
What can be gained by increasing our understanding of other gynecologic cancers or other parts of the female reproductive system? OCRA’s Scientific Advisory Committee (SAC) is comprised of doctors and … Continued
You may hear the terms “uterine cancer” and “endometrial cancer” used interchangeably. But uterine cancer is an umbrella term that includes two distinct cancer types — endometrial cancer and uterine … Continued
Endometriosis and endometrial cancer are often confused because the names of these two conditions sound so much alike. In fact, they are very different. Endometriosis is not cancer, and having endometriosis does … Continued
NCCN guidelines for the management of ovarian cancer, as well as fallopian and primary peritoneal cancers, specify that patients diagnosed with those diseases should have germline and somatic testing. But … Continued
Many ovarian cancer patients and survivors wonder what the ideal diet for ovarian cancer may be. In a nutshell – there is no simple answer. In this article, adapted from … Continued
Over the past decade, a new class of drugs called PARP inhibitors have been approved by the Food and Drug Administration (FDA) for use in ovarian cancer. Three FDA-approved PARP … Continued
Get email updates about research news, action alerts, and ways to join the fight.
